Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer

Diseases of the Colon and Rectum

Volumn 44, Issue 4, 2001, Pages 549-557

  Font, Albert ^a   Abad, Albert ^a   Monzó, Mariano ^a,b   Sanchez, Jose J ^c   Guillot, Monica ^a   Manzano, Jose L ^a   Piñol, Marta ^a   Ojanguren, Isabel ^a   Rosell, Rafael ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF MADRID   (Spain)

Author keywords

Colorectal cancer; Deleted in colorectal cancer (DCC) gene; K ras mutations; Loss of heterozygosity; Polymerase chain reaction; Prognostic marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ALLELISM; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 18Q; CODON; COLORECTAL CANCER; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POINT MUTATION; PROGNOSIS;

EID: 0035059910     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02234328     Document Type: Article

References (39)

1. Prognosis of node-positive colon cancer
2. Survival after curative resection of lymph node negative colorectal carcinoma
3. Event free and overall survival is increased by FUFA in resected B colon cancer: A pooled analysis of five randomized trials (RCTS)
4. Ras genes
5. Genetic alterations during colorectal-tumor development
6. Prognostic significance of K-ras mutations in colorectal carcinoma
7. Survival and acquired genetic alterations in colorectal cancer
8. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer
9. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis
10. Mutations in the p53 suppressor gene do not correlate with c-K-ras oncogene mutations in colorectal cancer
11. Allelic loss of chromosome 18q and prognosis in colorectal cancer
12. The DCC protein and prognosis in colorectal cancer
13. A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed paraffin-embedded tissues
14. Ras oncogenes in human cancer. A review
15. Alleotype of colorectal carcinomas
16. K-ras mutation in colorectal cancer: Relations to patient age, sex and tumor location
17. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver
18. A genetic model for colorectal tumorigenesis
19. Ki-ras mutation and p53 overexpression predict clinical behaviour of colorectal cancer: A southwest oncology group study
20. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer
21. Prognostic factors of colorectal cancer: K-ras mutation, overexpression of the p53 protein, and cell proliferative activity
22. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance
23. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival
24. Mutant K-ras oncogenes in colon cancers do not predict patient's chemotherapy response or survival
25. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon
26. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers
27. C-Ki-ras activation and the biological behaviour of proximal and distal colonic adenocarcinomas
28. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients
29. Prognostic value of K-ras 12 genotypes in patients with advanced non-small cell lung cancer receiving carboplatin with either intravenous or chronic oral dose etoposide
30. Increased resistance to cis-diammine-dichoroplatinum (II) in NIH3T3 cells transformed by ras oncogenes
31. Ras oncogene-induced sensitization to 1-β-D-arabinofuranosylcytosine
32. Kirsten ras mutations in patients with colorectal cancer: The multicenter RASCAL study
33. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver
34. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer
35. K-ras genotypes and prognosis in non-small-cell lung cancer
36. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
37. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator
38. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
39. Postoperative management of stage II/III colon cancer: A decision analysis